Validación del índice QOL-RA (Quality of Life-Rheumatoid Arthritis) en una cohorte argentina de pacientes con artritis reumatoidea

Carolina Ayelen Isnardi; Dafne Capelusnik; Emilce Edith Schneeberger; Marcela Bazzarelli; Laura Barloco; Eliana Blanco; Cristian Alejandro Benítez; Federico Luján Benavídez; Santiago Scarafia; María Alicia Lazaro; Rodolfo Pérez Alamino; Francisco Colombres; María Paula Kohan; Julia Sosa; Luciana González Lucero; Ana Lucía Barbaglia; Hernán Maldonado Ficco; Gustavo Citera

doi:10.47196/rar.v29i1.539

Carolina Ayelen Isnardi Instituto de Rehabilitación Psicofísica, Ciudad Autónoma de Buenos Aires, Argentina
Dafne Capelusnik Instituto de Rehabilitación Psicofísica, Ciudad Autónoma de Buenos Aires, Argentina
Emilce Edith Schneeberger Instituto de Rehabilitación Psicofísica, Ciudad Autónoma de Buenos Aires, Argentina
Marcela Bazzarelli Hospital Interzonal General de Agudos Petrona V. de Cordero, Buenos Aires, Argentina
Laura Barloco Hospital Interzonal General de Agudos Petrona V. de Cordero, Buenos Aires, Argentina
Eliana Blanco Hospital General de Agudos Dr. Cosme Argerich, Ciudad Autónoma de Buenos Aires, Argentina
Cristian Alejandro Benítez Hospital General de Agudos Dr. Cosme Argerich, Ciudad Autónoma de Buenos Aires, Argentina
Federico Luján Benavídez Hospital General de Agudos Dr. Cosme Argerich, Ciudad Autónoma de Buenos Aires, Argentina
Santiago Scarafia Instituto de Asistencia Reumatológica Integral, Buenos Aires, Argentina
María Alicia Lazaro Instituto de Asistencia Reumatológica Integral, Buenos Aires, Argentina
Rodolfo Pérez Alamino Hospital de Clínicas Nicolás Avellaneda, Tucumán, Argentina
Francisco Colombres Hospital de Clínicas Nicolás Avellaneda, Tucumán, Argentina
María Paula Kohan Hospital General de Agudos Dr. Enrique Tornú, Ciudad Autónoma de Buenos Aires, Argentina
Julia Sosa Hospital General de Agudos Dr. Enrique Tornú, Ciudad Autónoma de Buenos Aires, Argentina
Luciana González Lucero Hospital Ángel C. Padilla, Tucumán, Argentina
Ana Lucía Barbaglia Hospital Ángel C. Padilla, Tucumán, Argentina
Hernán Maldonado Ficco Hospital Ángel C. Padilla, Tucumán, Argentina
Gustavo Citera Instituto de Rehabilitación Psicofísica, Ciudad Autónoma de Buenos Aires, Argentina

DOI: https://doi.org/10.47196/rar.v29i1.539

Palabras clave: artritis reumatoidea, calidad de vida, QOL-RA

Resumen

El autocuestionario QOL-RA es una herramienta diseñada para valorar la calidad de vida de los pacientes con Artritis Reumatoidea (AR). No requiere licencia para su uso. Objetivo: validar el cuestionario QOL-RA en una cohorte de pacientes con AR en Argentina.

Citas

I. Maldonado Coco J, Citera G. Reumatología. 1era edición. Capítulo 17. Pág. 226-33.

II. Orbaia A, Bingham C. Patient Reported Outcomes in Rheumatoid Arthritis Clinical Trials. Curr Rheumatol Rep 2015;17(4):501.

III. Ballina García J. Medición de la calidad de vida en la artritis reumatoide. Rev Esp Reumatol 2002;29(2):56-64.

IV. Linde L, Sorensen J, Ostergaard M, Horslev Petersen J, Lund Hetland M. Health-Related Quality of Life: Validity, Reliability, and Responsiveness of SF-36, EQ-15D, EQ-5D, RAQoL, and HAQ in Patients with Rheumatoid Arthritis. J Rheumatol 2008;35(8):1528-37.

V. Buchbinder R, Bombardier C, Yeung M, Tugwell P. Which outcome measures should be used in rheumatoid arthritis clinical trials? Clinical and quality-of-life measures responsiveness to treatment in a randomized controlled trial. Arthritis Rheum 1995;38(11):1568-80.

VI. Wells G, Boers M, Shea B, Tugwell P, Westhovens R, Suárez-Almazor M, et al. Sensitivity to change of generic quality of life instruments in patients with rheumatoid arthritis: preliminary findings in the generic health OMERACT study. OMERACT/ILAR Task Force on Generic Quality of Life. Life Outcome Measures in Rheumatology. International League of Associations for Rheumatology. J Rheumatol 1999;26(1):217-21.

VII. Tugwell P, Boers M. Developing consensus on preliminary core efficacy endpoints for rheumatoid arthritis clinical trials. OMERACT Committee. J Rheumatol 1993;20(3):555-6.

VIII. Felson D, Aderson J, Boers M, Bombardier C, Chernoff M, Fried B, et al. The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum 1993;36(6):729-40.

IX. Tugwell P, Idzerda L, Wells G. Generic quality-of-life assessment in rheumatoid arthritis. Am J Manag Care 2008;14(4):234.

X. Cabasés Hita J, Sánchez Iriso E, Ollo López A, Errea Rodríguez M. Ministerio de Sanidad, Servicios Sociales e Igualdad. Encuesta Nacional de Salud. España 2011/12. Calidad de vida relacionada con la salud en adultos: EQ-5D-5L. Serie Informes monográficos no 3. Madrid: Ministerio de Sanidad, Servicios Sociales e Igualdad, 2014.

XI. Whalley D, McKenna S, de Jong Z, van der Heijde D. Quality of life in rheumatoid arthritis. Br J Rheumatol 1997;36(8):884-8.

XII. Danao L, Padilla G, Johnson D. An English and Spanish Quality of Life Measure for Rheumatoid Arthritis. Arthritis Rheum 2001;45(2):167-73.

XIII. Funovits J, Aletaha D, Bykerk V, Combe B, Dougados M, Emery P, et al. The 2010 American College of Rheumatology/ European League Against Rheumatism classification criteria for rheumatoid arthritis: methodological report phase I. Ann Rheum Dis 2010;69(9):1589-95.

XIV. Citera G, Arriola M, Maldonado-Cocco J, Rosemffet M, Sánchez M, Goñi M, et al. Validation and crosscultural adaptation of an Argentine spanish version of the health assessment questionnaire disability index. J Clin Rheumatol 2004;10(3):110-5.

XV. Kroenke K, Spitzer R, Williams J. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16(9):606-13.

XVI. Prevoo M, van‘ t Hof M, Kuper H, van Leeuven M, van de Putte L, van Riel P. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38(1):44-8.

XVII. Aletaha D, Nell V, Stamm T, Uffmann M, Pflugbeil S, Machold K, et al. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther 2005;7(4):R796-806.

XVIII. Smolen J, Breedveld F, Schiff M, Kalden J, Emery P, Eberl G, et al. A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology 2003;42(2):244-57.

XIX. Curet A, Rillo O, Chaparro del Moral R, Papasidero S, Citera G, Maldonado Cocco JJ, et al. Modificación y aplicación de un índice de actividad simplificado (IAS) en pacientes con artritis reumatoidea. Rev Argent Reumatol 2005;16(1):13.

XX. O rbaia A, Bingham C. Patient Reported Outcomes in Rheumatoid Arthritis Clinical Trials. Curr Rheumatol Rep 2015;17(4):501.

XXI. Meenan R, Mason J, Anderson J, Guccione A, Kazis L. AIMS2. The content and properties of a revised and expanded Arthritis Impact Measurement Scales Health Status Questionnaire. Arthritis Rheum 1992;35(1):1-10.

XXII. Lubben J, Blozik E, Gillmann G, Iliffe S, von Renteln Kruse W, Beck JC, et al. Performance of an abbreviated version of the Lubben Social Network Scale among three European community-dwelling older adult populations. Gerontologist 2006;46(4):503-13.

XXIII. Andresen E, Malmgren J, Carter W, Patrick D. Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). Am J Prev Med 1994;10(2):77-84.

XXIV. Scoggins J, Patrick D. The use of patient-reported outcomes instruments in registered clinical trials: Evidence from ClinicalTrials.gov. Contemp Clin Trials 2009;30(4):289-92.

XXV. Sociedad Argentina de Reumatología. Grupo de Estudio de Artritis Reumatoidea. Actualización de las guías de práctica clínica en el tratamiento de la Artritis Reumatoidea. Rev Argent Reumatol 2013;24(Supl esp):1-144.

XXVI. De Jong Z, van der Heijde D, McKenna S, Whalley D. The reliability and construct validity of the RAQoL: a rheumatoid arthritis-specific quality of life instrument. Br J Rheumatol 1997;36(8):878-83.

XXVII. Hurst N, Jobanputra P, Hunter M, Lambert M, Lochhead A, Brown H. Validity of Euroqol--a generic health status instrument--in patients with rheumatoid arthritis. Economic and Health Outcomes Research Group. Br J Rheumatol 1994;33(7):655-62.

XXVIII. Hurst N, Kind P, Ruta D, Hunter M, Stubbings A. Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). Br J Rheumatol 1997;36(5):551-9.

XXIX. Talamo J, Frater A, Gallivan S, Young A. Use of the short form 36 (SF36) for health status measurement in rheumatoid arthritis. Br J Rheumatol 1997;36(4):463-9.

XXX. Neville C, Whalley D, McKenna S, Le Comte M, Fortin P. Adaptation and validation of the rheumatoid arthritis quality of life scale for use in Canada. J Rheumatol 2001;28(7):1505-10.

XXXI. Garip Y, Eser F, Bodur H. Health-related quality of life in rheumatoid arthritis: comparison of RAQoL with other scales in terms of disease activity, severity of pain, and functional status. Rheumatol Int 2011;31(6):769-72.

XXXII. Bazzichi L, Maser J, Piccinni A, Rucci P, Del Debbio A, Vivarelli L, et al. Quality of life in rheumatoid arthritis: impact of disability and lifetime depressive spectrum symptomatology. Clin Exp Rheumatol 2005;23(6):783-8.

XXXIII. Marra C, Woolcott J, Kopec J, Shojania K, Offer R, Brazier J, et al. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Soc Sci Med 2005;60(7):1571-82.

XXXIV. L egge A, Blanchard C, Hanly J. Physical activity and sedentary behavior in patients with systemic lupus erythematosus and rheumatoid arthritis. Open Access Rheumatol 2017;9(8):191-200.

XXXV. Conigliaro P, Triggianese P, Ippolito F, Lucchetti R, Chimenti M, Perricone R. Insights on the role of physical activity in patients with rheumatoid arthritis. Drug Dev Res 2014;75 Suppl 1:S54-6.